Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, pointing to a metabolic effect beyond appetite suppression. If confirmed in people, the result could help explain the drugs’ strong benefits against obesity and diabetes and inform more comprehensive treat